Cargando…

Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study

Detalles Bibliográficos
Autores principales: Zhou, Jiandong, Lee, Sharen, Guo, Cosmos Liutao, Chang, Carlin, Liu, Tong, Leung, Keith Sai Kit, Wai, Abraham Ka Chung, Cheung, Bernard Man Yung, Tse, Gary, Zhang, Qingpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846462/
https://www.ncbi.nlm.nih.gov/pubmed/33524539
http://dx.doi.org/10.1016/j.phrs.2021.105473
_version_ 1783644736380207104
author Zhou, Jiandong
Lee, Sharen
Guo, Cosmos Liutao
Chang, Carlin
Liu, Tong
Leung, Keith Sai Kit
Wai, Abraham Ka Chung
Cheung, Bernard Man Yung
Tse, Gary
Zhang, Qingpeng
author_facet Zhou, Jiandong
Lee, Sharen
Guo, Cosmos Liutao
Chang, Carlin
Liu, Tong
Leung, Keith Sai Kit
Wai, Abraham Ka Chung
Cheung, Bernard Man Yung
Tse, Gary
Zhang, Qingpeng
author_sort Zhou, Jiandong
collection PubMed
description
format Online
Article
Text
id pubmed-7846462
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-78464622021-02-01 Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study Zhou, Jiandong Lee, Sharen Guo, Cosmos Liutao Chang, Carlin Liu, Tong Leung, Keith Sai Kit Wai, Abraham Ka Chung Cheung, Bernard Man Yung Tse, Gary Zhang, Qingpeng Pharmacol Res Article Elsevier Ltd. 2021-03 2021-01-30 /pmc/articles/PMC7846462/ /pubmed/33524539 http://dx.doi.org/10.1016/j.phrs.2021.105473 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zhou, Jiandong
Lee, Sharen
Guo, Cosmos Liutao
Chang, Carlin
Liu, Tong
Leung, Keith Sai Kit
Wai, Abraham Ka Chung
Cheung, Bernard Man Yung
Tse, Gary
Zhang, Qingpeng
Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
title Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
title_full Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
title_fullStr Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
title_full_unstemmed Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
title_short Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
title_sort anticoagulant or antiplatelet use and severe covid-19 disease: a propensity score-matched territory-wide study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846462/
https://www.ncbi.nlm.nih.gov/pubmed/33524539
http://dx.doi.org/10.1016/j.phrs.2021.105473
work_keys_str_mv AT zhoujiandong anticoagulantorantiplateletuseandseverecovid19diseaseapropensityscorematchedterritorywidestudy
AT leesharen anticoagulantorantiplateletuseandseverecovid19diseaseapropensityscorematchedterritorywidestudy
AT guocosmosliutao anticoagulantorantiplateletuseandseverecovid19diseaseapropensityscorematchedterritorywidestudy
AT changcarlin anticoagulantorantiplateletuseandseverecovid19diseaseapropensityscorematchedterritorywidestudy
AT liutong anticoagulantorantiplateletuseandseverecovid19diseaseapropensityscorematchedterritorywidestudy
AT leungkeithsaikit anticoagulantorantiplateletuseandseverecovid19diseaseapropensityscorematchedterritorywidestudy
AT waiabrahamkachung anticoagulantorantiplateletuseandseverecovid19diseaseapropensityscorematchedterritorywidestudy
AT cheungbernardmanyung anticoagulantorantiplateletuseandseverecovid19diseaseapropensityscorematchedterritorywidestudy
AT tsegary anticoagulantorantiplateletuseandseverecovid19diseaseapropensityscorematchedterritorywidestudy
AT zhangqingpeng anticoagulantorantiplateletuseandseverecovid19diseaseapropensityscorematchedterritorywidestudy